Parvovirus B19 Antibody, IgG
Also known as: PARVO G
Use
The Parvovirus B19 Antibody, IgG test is used to detect the presence of IgG antibodies to Parvovirus B19, which may indicate a past or current infection. This antibody test helps in the diagnosis of erythema infectiosum or fifth disease. The best evidence for current infection is a significant change on two appropriately timed specimens, where both tests are done in the same laboratory at the same time.
Special Instructions
Not recommended as a standalone test. Preferred test is Parvovirus B19 Antibodies, IgG and IgM (0065120). Mark specimens plainly as 'acute' or 'convalescent.'
Limitations
The test may not detect antibodies in early infection before seroconversion or in the case of immunocompromised patients who might not produce sufficient antibodies. Environmental and technical factors may affect assay performance, leading to false positives or negatives. Equivocal results suggest repeat testing in 7-21 days may be helpful.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 5273-8
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.3 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Separate from cells ASAP or within 2 hours of collection. Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens.
Storage Instructions
Refrigerated storage required. Avoid repeated freeze/thaw cycles.
Causes for Rejection
Bacterially contaminated, heat-inactivated, hemolyzed, icteric, lipemic, or turbid specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year |